Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus

Journal of Virology

Volumn 83, Issue 23, 2009, Pages 12027-12036

  Finn, Jonathan D ^a   Bassett, Jennifer ^a   Millar, James B ^a   Grinshtein, Natalie ^a   Yang, Teng Chih ^a   Parsons, Robin ^a   Evelegh, Carole ^a   Wan, Yonghong ^a   Parks, Robin J ^b   Bramson, Jonathan L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; DOXYCYCLINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; OVALBUMIN; VIRAL VACCINES;

ADENOVIRIDAE;

EID: 70450184456     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00593-09     Document Type: Article

References (55)

1. + T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J. Immunol. 175: 4686-4696.
2. + T cells and antiviral protection. J. Immunol. 175:4677-4685.
3. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11:748-756.
4. + T cells after infection. Nat. Immunol. 3:619-626.
5. Barouch, D. H., and G. J. Nabel. 2005. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum. Gene Ther. 16:149-156.
6. Bevan, M. J., and P. J. Fink. 2001. The CD8 response on autopilot. Nat. Immunol. 2:381-382.
7. Bramson, J. L., M. Hitt, J. Gauldie, and F. L. Graham. 1997. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther. 4:1069-1076.
8. Capone, S., A. Meola, B. B. Ercole, A. Vitelli, M. Pezzanera, L. Ruggeri, M. E. Davies, R. Tafi, C. Santini, A. Luzzago, T. M. Fu, A. Bett, S. Colloca, R. Cortese, A. Nicosia, and A. Folgori. 2006. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques. J. Virol. 80:1688-1699. (Pubitemid 43228711)
9. + T cell responses expand when antigen presentation overcomes T cell self-regulation. J. Immunol. 180:64-71.
10. Furth, P. A., L. St. Onge, H. Boger, P. Gruss, M. Gossen, A. Kistner, H. Bujard, and L. Hennighausen. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91:9302-9306.
11. Gallo, P., S. Dharmapuri, B. Cipriani, and P. Monaci. 2005. Adenovirus as vehicle for anticancer genetic immunotherapy. Gene Ther. 12(Suppl. 1):S84-S91. (Pubitemid 41541756)
12. Gao, W., A. C. Soloff, X. Lu, A. Montecalvo, D. C. Nguyen, Y. Matsuoka, P. D. Robbins, D. E. Swayne, R. O. Donis, J. M. Katz, S. M. Barratt-Boyes, and A. Gambotto. 2006. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80:1959-1964. (Pubitemid 43228735)
13. + T cell responses against liver stages of murine malaria. J. Immunol. 171:964-970.
14. + T cell responses to malaria liver stages. Proc. Natl. Acad. Sci. USA 99:11819-11824.
15. Harrington, L. E., R. van der Most, J. L. Whitton, and R. Ahmed. 2002. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76:3329-3337.
16. + T cells. J. Exp. Med. 204:1625-1636.
17. + T lymphocytes. J. Immunol. 179:6725-6733.
18. + memory T cell subsets. Proc. Natl. Acad. Sci. USA 101:5610-5615.
19. + T cells are more protective but slower to acquire a central-memory phenotype. J. Exp. Med. 203:919-932.
20. Jackson, S. S., J. E. Schmitz, M. J. Kuroda, P. F. McKay, S. M. Sumida, K. L. Martin, F. Yu, M. A. Lifton, D. A. Gorgone, and N. L. Letvin. 2005. Evaluation of CD62L expression as a marker for vaccine-elicited memory cytotoxic T lymphocytes. Immunology 116:443-453.
21. + T cell fates via the graded expression of T-bet transcription factor. Immunity 27:281-295.
22. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-1198.
23. + T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181:4188-4198.
24. + T-cell memory in a model of localized transient infection. Immunol. Rev. 211:133-145.
25. + T cell responses during a persistent virus infection. J. Immunol. 174:7950-7960.
26. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 102:9571-9576.
27. Krebs, P., E. Scandella, B. Odermatt, and B. Ludewig. 2005. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus. J. Immunol. 174:4559-4566. (Pubitemid 40504535)
28. Lane, C., J. Leitch, X. Tan, J. Hadjati, J. L. Bramson, and Y. Wan. 2004. Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res. 64:1509-1514. (Pubitemid 38235624)
29. Li, S., E. Locke, J. Bruder, D. Clarke, D. L. Doolan, M. J. Havenga, A. V. Hill, P. Liljestrom, T. P. Monath, H. Y. Naim, C. Ockenhouse, D. C. Tang, K. R. Van Kampen, J. F. Viret, F. Zavala, and F. Dubovsky. 2007. Viral vectors for malaria vaccine development. Vaccine 25:2567-2574. (Pubitemid 46400924)
30. Liu, J., K. L. O'Brien, D. M. Lynch, N. L. Simmons, A. La Porte, A. M. Riggs, P. Abbink, R. T. Coffey, L. E. Grandpre, M. S. Seaman, G. Landucci, D. N. Forthal, D. C. Montefiori, A. Carville, K. G. Mansfield, M. J. Havenga, M. G. Pau, J. Goudsmit, and D. H. Barouch. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91.
31. Masopust, D., S. J. Ha, V. Vezys, and R. Ahmed. 2006. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177:831-839.
32. McElrath, M. J., S. C. De Rosa, Z. Moodie, S. Dubey, L. Kierstead, H. Janes, O. D. Defawe, D. K. Carter, J. Hural, R. Akondy, S. P. Buchbinder, M. N. Robertson, D. V. Mehrotra, S. G. Self, L. Corey, J. W. Shiver, and D. R. Casimiro. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894-1905.
33. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165:6833-6839. (Pubitemid 32001151)
34. Ng, P., R. J. Parks, D. T. Cummings, C. M. Evelegh, and F. L. Graham. 2000. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum. Gene Ther. 11:693-699.
35. Obar, J. J., S. Fuse, E. K. Leung, S. C. Bellfy, and E. J. Usherwood. 2006. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J. Virol. 80:8303-8315.
36. Pascual, D. W., N. Walters, and P. Hillemeyer. 1998. Repeated intratracheal instillations of nonreplicating adenovirus 2 vector attenuate CTL responses and IFN-γ production. J. Immunol. 160:4465-4472.
37. + T cell function and memory development. J. Immunol. 179: 8313-8321.
38. Reyes-Sandoval, A., S. Sridhar, T. Berthoud, A. C. Moore, J. T. Harty, S. C. Gilbert, G. Gao, H. C. Ertl, J. C. Wilson, and A. V. Hill. 2008. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei. Eur. J. Immunol. 38:732-741.
39. Schirmbeck, R., J. Reimann, S. Kochanek, and F. Kreppel. 2008. The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens. Mol. Ther. 16:1609-1616.
40. Stock, A. T., S. N. Mueller, A. L. van Lint, W. R. Heath, and F. R. Carbone. 2004. Prolonged antigen presentation after herpes simplex virus-1 skin infection. J. Immunol. 173:2241-2244.
41. + T cells: implications for their use as vaccines. Blood 110:1916-1923.
42. Thimme, R., V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher. 2005. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79:12112-12116. (Pubitemid 41279330)
43. + memory T cells and protective capacities in Listeria monocytogenes-infected mice upon rechallenge. J. Immunol. 182:4590-4600.
44. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78:5535-5545.
45. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-4927.
46. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234.
47. Wong, P., M. Lara-Tejero, A. Ploss, I. Leiner, and E. G. Pamer. 2004. Rapid development of T cell memory. J. Immunol. 172:7239-7245.
48. Wong, P., and E. G. Pamer. 2003. Feedback regulation of pathogen-specific T cell priming. Immunity 18:499-511. (Pubitemid 36513632)
49. Xing, Z., M. Santosuosso, S. McCormick, T. C. Yang, J. Millar, M. Hitt, Y. Wan, J. Bramson, and H. M. Vordermeier. 2005. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr. Gene Ther. 5:485-492.
50. + T-cell response following adenovirus vaccination. J. Virol. 77:13407-13411.
51. + T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J. Immunol. 176:200-210.
52. + T-cell response elicited by recombinant adenovirus vaccines. Mol. Ther. 15:997-1006.
53. Yang, T. C., J. B. Millar, N. Grinshtein, J. Bassett, J. Finn, and J. L. Bramson. 2007. T-cell immunity generated by recombinant adenovirus vaccines. Expert Rev. Vaccines 6:347-356.
54. Yang, Z. R., H. F. Wang, J. Zhao, Y. Y. Peng, J. Wang, B. A. Guinn, and L. Q. Huang. 2007. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Ther. 14:599-615. (Pubitemid 46912038)
55. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10:1104-1110.